The latest price target for Colgate-Palmolive (NYSE:CL) was reported by JP Morgan on February 3, 2025. The analyst firm set a price target for $97.00 expecting CL to rise to within 12 months (a possible 6.38% upside). 49 analyst firms have reported ratings in the last year.

The latest analyst rating for Colgate-Palmolive (NYSE:CL) was provided by JP Morgan, and Colgate-Palmolive maintained their overweight rating.

The last upgrade for Colgate-Palmolive Co happened on January 29, 2024 when Raymond James raised their price target to $91. Raymond James previously had a market perform for Colgate-Palmolive Co.

The last downgrade for Colgate-Palmolive Co happened on October 28, 2024 when Stifel changed their price target from $105 to $101 for Colgate-Palmolive Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Colgate-Palmolive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Colgate-Palmolive was filed on February 3, 2025 so you should expect the next rating to be made available sometime around February 3, 2026.

While ratings are subjective and will change, the latest Colgate-Palmolive (CL) rating was a maintained with a price target of $103.00 to $97.00. The current price Colgate-Palmolive (CL) is trading at is $91.18, which is out of the analyst’s predicted range.